سعر يوسترتك Yostiretic‏ 30 اقراص 2026

• Usually well tolerated; hyperkalaemia; nausea/anorexia, abdominal pain, flatulence and mild skin rash probably related to amiloride; other effects typical of diuretics.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Hyperkalaemia (serum potassium >5.5 mEq/L).General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Concomitant potassium-conserving agents (spironolactone, triamterene) or potassium supplementation/potassium-rich salt substitutes, except in severe refractory hypokalaemia with careful monitoring.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Anuria, acute or chronic renal insufficiency, diabetic nephropathy; hypersensitivity to the product or other sulfonamide-derived drugs.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• May cause hyperkalaemia (about 1-2% without renal impairment or diabetes; higher with renal impairment, diabetes, or with ACE inhibitors, ciclosporin or tacrolimus); potentially fatal, so monitor serum potassium carefully.General active-ingredient information · DailyMed (U.S. National Library of Medicine)
• Avoid if possible in diabetes; if used, monitor electrolytes and renal function frequently; stop at least 3 days before glucose tolerance testing. Caution in metabolic or respiratory acidosis.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• LithiumDiuretics reduce renal lithium clearance with high risk of lithium toxicity; generally should not be co-administered.DailyMed (U.S. National Library of Medicine)
• ACE inhibitors, ciclosporin, tacrolimusIncreased risk of hyperkalaemia with potassium-conserving agents.DailyMed (U.S. National Library of Medicine)

• Thiazides appear in breast milk (amiloride passes into rat milk); decide whether to discontinue nursing or the drug.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

• Monitor serum potassium (especially at initiation, dose changes and intercurrent illness), electrolytes, BUN and creatinine, particularly in renal impairment, diabetes and the elderly.General active-ingredient information · DailyMed (U.S. National Library of Medicine)

English text not available for this section.